EGFRvIII is a truncated isoform of the epidermal growth factor receptor (EGFR), belonging to a subfamily of receptor tyrosine kinases (HER1–4) mainly expressed in glioblastomas, and has been found to be a key target for organ tumors. This evidence concerns the gene EGFR and glioblastoma.